Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Hepatitis B and C virus and hepatocellular carcinoma
"Antibody to hepatitis C virus (anti-HCV) was detected in 18.7% of patients with hepatocellular carcinoma ma (HCC)a nd in 10.9% of controls (P<0.001).The corresponding prevalences of hepatitis B surface antigen [HBsAg] were 59.3% and 50.0%(P<0.001). Using paticnts with non-hepatic disease as contro...
Saved in:
| Format: | Article |
|---|---|
| Published: |
1997
|
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Hepatitis B and C virus and hepatocellular carcinoma
- Serum‐Based miRNA Panel as Diagnostic Biomarkers for Hepatitis C Virus‐Induced Hepatocellular Carcinoma: A Cross‐Sectional Study
- Serum Hepatitis C virus and hepatitis B surface antigenaemia patients with acute icteric hepatitis
- Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study
- Transcriptional and epigenetic regulation of Ca2+-signaling genes in hepatitis B-derived hepatocellular carcinoma and their association with the cancer hallmarks
- Seroprevalence rates of hepatitis c virus (hcv) antibody and hepatitis b virus surface antigen (hbsag) in blood donors in a southwestern nigerian city
- Nigeria butchers and hepatitis B virus infection